04/15/2024
4:09 PM | Coherus BioSciences (Filer)
| Form DEF 14A | |
04/15/2024
4:10 PM | Coherus BioSciences (Filer)
| Form DEFA14A | |
04/15/2024
4:11 PM | Coherus BioSciences (Filer)
| Form ARS | |
03/28/2024
3:04 PM | Coherus BioSciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/15/2024
4:13 PM | Coherus BioSciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
3:16 PM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
5:22 AM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/15/2024
6:56 PM | Coherus BioSciences (Issuer)
Wahlstrom Mats (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:03 PM | Coherus BioSciences (Issuer)
Wahlstrom Mats (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
7:09 AM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
Coherus BioSciences (Subject)
| Form SC 13G/A | |
01/23/2024
7:04 PM | Coherus BioSciences (Issuer)
McMichael Bryan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
7:05 PM | Coherus BioSciences (Issuer)
Reider Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
7:07 PM | Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
1:08 PM | Coherus BioSciences (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024
7:01 AM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
8:39 PM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
8:41 PM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
6:37 PM | Coherus BioSciences (Issuer)
McMichael Bryan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
5:58 PM | Coherus BioSciences (Issuer)
Reider Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:04 PM | Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:13 PM | Coherus BioSciences (Issuer)
Reider Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:14 PM | Coherus BioSciences (Issuer)
McMichael Bryan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:42 PM | Coherus BioSciences (Issuer)
Stilwell McDavid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
7:49 PM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
3:47 PM | Coherus BioSciences (Issuer)
Reider Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
4:16 PM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
1:45 PM | Coherus BioSciences (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G/A | |
11/24/2023
3:04 PM | Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
4:52 PM | Coherus BioSciences (Subject)
Lanfear Dennis M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
5:07 AM | Coherus BioSciences (Filer)
| Form 8-K/A | |
11/06/2023
3:31 PM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
3:35 PM | Coherus BioSciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
5:07 AM | Coherus BioSciences (Filer)
| Form 8-K/A | |
10/27/2023
3:19 PM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
4:03 PM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
1:34 PM | BlackRock Inc. (Filed by)
Coherus BioSciences (Subject)
| Form SC 13G/A | |
09/12/2023
5:04 AM | Coherus BioSciences (Filer)
| Form 424B5 | |
09/12/2023
5:07 AM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
8:12 AM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2023
3:05 PM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The #1 Crypto for AI (Ad) We’ve issued an urgent landmark trade alert for a new crypto wonder.
So, I decided to give you this heads-up before it’s too late.
It’s urgent because it’s what we consider “The #1 Crypto for the AI World.” Learn more about it by watching THIS NOW. |
07/26/2023
11:15 PM | Coherus BioSciences (Filer)
| Form EFFECT | |
07/24/2023
3:42 PM | Coherus BioSciences (Filer)
| Form S-4/A | |
07/20/2023
4:01 PM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/20/2023
4:10 PM | Coherus BioSciences (Issuer)
Ryan Michael Lee (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/20/2023
4:11 PM | Coherus BioSciences (Issuer)
Ryan Michael Lee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
4:03 PM | Coherus BioSciences (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
06/16/2023
4:11 PM | Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
| Form 425 | |
06/16/2023
4:12 PM | Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
| Form 425 | |
06/16/2023
4:14 PM | Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
| Form 425 | |
06/16/2023
4:14 PM | Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
| Form 425 | |
06/16/2023
4:16 PM | Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
| Form 425 | |
06/16/2023
4:17 PM | Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
| Form 425 | |
06/16/2023
7:08 AM | Coherus BioSciences (Subject)
Surface Oncology, Inc. (Filed by)
| Form 425 | |
06/16/2023
6:06 AM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
6:09 AM | Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
| Form 425 | |
06/15/2023
3:41 PM | Coherus BioSciences (Issuer)
McMichael Bryan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:42 PM | Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:39 PM | Coherus BioSciences (Issuer)
Reider Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:40 PM | Coherus BioSciences (Issuer)
Stilwell McDavid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:05 AM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2023
4:07 PM | Coherus BioSciences (Issuer)
Newcomer Lee Nisley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:08 PM | Coherus BioSciences (Issuer)
STOLPER MARK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:09 PM | Coherus BioSciences (Issuer)
Wahlstrom Mats (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
11:57 AM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2023
8:15 AM | CITADEL ADVISORS LLC (Filed by)
Coherus BioSciences (Subject)
| Form SC 13G | |
05/16/2023
5:07 AM | Coherus BioSciences (Filer)
| Form 424B5 | |
05/15/2023
4:23 PM | Coherus BioSciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
